Patent Assignment
Reel/Frame 019605/0632
Assignment of Assignor's Interest
Recorded: 2007-07-31
Pages: 4
Assignee
RESEARCH CORPORATION TECHNOLOGIES, INC.
101 NORTH WILMOT, 6TH FLOOR, TUCSON, ARIZONA, 85711-3335
Covered Property
(1)
Methods of Treating Inflammation and Compositions Therefor
Patent:
5,917,014 →
Application:
08/468,865 →
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 22, 1998
From: RESEARCH CORPORATION TECHNOLOGIES, INC.
To: UNIVERSITY OF ALBERTA
Reel/Frame 009208/0781 →
Assignment of Assignor's Interest
Sep 8, 1998
From: ALBERTA, UNIVERSITY OF THE
To: VIRON THERAPEUTICS, INC.
Reel/Frame 009445/0844 →
Security Interest
Dec 8, 2003
From: VIRON THERAPEUTICS INC.
To: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA
Reel/Frame 014754/0290 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 014754/0221 →
Security Interest
Dec 9, 2003
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG (AS ASSIGNEE OF NOVARTIS INTERNATIONAL AG); ROYAL BANK OF CANADA; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
Reel/Frame 014754/0266 →
Security Agreement
Jul 12, 2004
From: VIRON THERAPEUTICS INC.
To: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
Reel/Frame 016256/0117 →
Security Agreement
Jul 8, 2008
From: EASTERN TECHNOLOGY SEED INVESTMENT FUND LIMITED PARTNERSHIP; TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0109 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG; ROYAL BANK OF CANADAD; GENECHEM TECHNOLOGIES VENTURE FUND, L.P.
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0124 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0143 →
Security Agreement
Jul 8, 2008
From: TRUDELL MEDICAL LIMITED; NOVARTIS PHARMA AG
To: VIRON THERAPEUTICS INC.
Reel/Frame 021205/0135 →